In this article, we will take a look at the 13 Best Blue Chip Stocks to Buy Now.

Blue-chip stocks are well-positioned to emerge as the ultimate winners amid the Trump tariffs and a shift in monetary policy. According to Brian Gardner, Chief Washington policy strategist at Stifel Financial, large-cap companies boast of strong negotiating power to navigate the tariff environment. Likewise, he expects the companies to navigate with ease a changing economic environment

”[Small caps] also probably don’t have the ability to negotiate any exemptions. Their ability to pivot from one country to another to maybe arbitrage the tariff risk is probably reduced.” Gardner said.

The remarks come amid growing speculation about a potential rotation in the equity markets, following one of the longest bull runs driven by blue-chip stocks. Goldman Sachs CEO has already warned of a possible 10- to 20% drawdown in the equity market as investors resort to profit-taking.

“A 10 to 15% drawdown happens often, even though positive market cycles. It’s not something that changes your fundamental, your structural belief as to how you want to allocate capital,” said Goldman Sachs CEO David Solomon

Morgan Stanley CEO Ted Pick expects a healthy drawdown that does not signal a market crisis. Such drawdowns would offer investors opportunities to capitalize on pullbacks from current premium valuations. Blue-chip stocks are expected to continue driving the market higher, even during a drawdown, as the US Federal Reserve embarks on a monetary policy easing spree.

Amid heightened valuation concerns with major indices at all-time highs, the focus is slowly shifting towards large-cap stocks trading at discounted valuations, backed by solid underlying fundamentals.

With that in mind, let’s take a look at some of the best blue chip stocks to buy now.

Our Methodology

To identify the best blue chip stocks to buy now, we conducted a detailed review of several prominent blue chip ETFs and recent relevant financial media reports. We shortlisted companies that enjoy strong support from hedge funds, carry favorable analyst sentiment, and have been recently making headlines. Finally, we ranked the selected stocks according to the scale of hedge fund ownership reported in the second quarter of 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

Best Blue Chip Stocks to Buy Now

13. Dell Technologies Inc. (NYSE:DELL)

Number of Hedge Fund Holders: 54

Dell Technologies Inc. (NYSE:DELL) is one of the best blue-chip stocks to buy now. On November 3, analysts at Evercore ISI reiterated an “Outperform” rating on Dell Technologies Inc. (NYSE:DELL) and raised the price target to $180 from $160. The price target hike comes as the research firm expects the company to benefit from a significant order of ancillary equipment.

With IREN inking a 5-year contract worth $9.7 billion with Microsoft for the supply of GB300 GPUs, Dell is poised to attract a $5.8 billion order for ancillary equipment. IREN purchases high-performance AI infrastructure hardware from Dell for its cloud services, which support clients such as Microsoft.

The IREN deal is poised to strengthen Dell’s Tier 2 customer base, which currently includes CoreWeave and xAI. The IREN program is also expected to account for about 25% of Dell’s total AI revenue. As part of the IREN Microsoft deal, Dell is to handle the complete delivery and integration of systems for its customers. Evercore ISI expects the company to capitalize on the expansion of its Tier 2 customer base.

Dell Technologies announced on October 21, that it has advanced its AI Data Platform to help enterprises unlock faster and more reliable insights by breaking down data silos. The platform, part of the Dell AI Factory and integrated with NVIDIA’s reference design, combines storage engines, data engines, cyber resiliency, and management services to support demanding AI workloads. Dell PowerScale and ObjectScale deliver enhanced scalability and performance, with PowerScale offering simplified NAS access and GPU-scale efficiency, while ObjectScale provides high-speed, S3‑native object storage with new software-defined options and deeper AWS integration.

Dell Technologies Inc. (NYSE:DELL) designs, develops, sells, and supports a wide range of computers and IT solutions. Its product line includes laptops, desktops, and monitors, as well as advanced infrastructure solutions such as servers, data storage, and artificial intelligence for businesses.

12. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holders: 67

McKesson Corporation (NYSE:MCK) is one of the best blue-chip stocks to buy now. On November 6, Morgan Stanley raised its price target on McKesson Corporation (NYSE:MCK) to $916 from $857, keeping its Overweight rating. Analysts pointed to the company’s strong organic growth and operational momentum reflected in updated guidance, though they noted investor reaction could be restrained given the high expectations already priced in.

A day earlier, on November 5, McKesson posted second‑quarter results for Fiscal 2026. Revenue climbed 10% to $103.2 billion, helped by rising prescription volumes and broader distribution of oncology and multispecialty products. Earnings per share jumped to $8.92, compared with $1.87 a year ago, as the company moved past charges tied to earlier divestitures and restructuring.

Operating cash flow reached $2.4 billion, with free cash flow at $2.2 billion. In the first half of the fiscal year, McKesson returned $1.6 billion to shareholders through buybacks and dividends, underscoring its focus on capital returns.

Looking ahead, the company lifted its adjusted earnings guidance to $38.35–$38.85 per share for Fiscal 2026. CEO Brian Tyler said record revenue and earnings highlight McKesson’s strength in oncology, multispecialty, and biopharma services, adding that the company is well positioned to deliver long‑term value.

McKesson Corporation (NYSE:MCK) is a diversified healthcare services company that distributes pharmaceuticals and medical-surgical supplies.